Recombinant Vinculin (VCL)
Cat#:TP05933应用:Positive Control; Immunogen; SDS-PAGE; WB
Product Name: | Vinculin Recombinant Rabbit mAb |
Cat No.: | RMA02935 |
Clonality: | Monoclonal |
Species Reactivity: | Human, Mouse, Rat |
Tested Applications: | WB, IHC, ICC/IF, FC, IP |
Recommended Dilution: | WB: 1:2000 ICC/IF: 1:50 FC: 1:50 IP: 1:20 |
Size: | 30ul 50ul 100uL |
Format: | Liquid |
Source: | Rabbit |
Purification Method: | Affinity Purification |
Isotype: | IgG |
Conjugate: | Un-conjugated |
Storage: | Store at -20°C. Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide a |
Immunogen: | A synthetic peptide of human Vinculin |
Calculated Molecular Weight: | 124 kDa |
Observed Molecular Weight: | 124 kDa |
GenBank Accession Number: | P18206 |
Gene ID (NCBI): | 7414 |
Synonyms: | MV; MVCL; CMD1W; CMH15; HEL114 |
Background: | Vinculin is a cytoskeletal protein associated with cell-cell and cell-matrix junctions, where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined. [provided by RefSeq, Jul 2008] |
Category: | Primary Ab |